Kotschy M, Kassian J, Lampka M, Rajewski W
Katedry i Zakładu Patofizjologii A.M. w Bydgoszczy.
Pol Merkur Lekarski. 1997 Feb;2(8):93-5.
In the plasma of fourty dialyzed patients with chronic renal insufficiency in comparison to controls a mild decrease of AT III activity, low activity of PAI-1 and alfa-2 AP with normal activity alfa-2 M. and alfa-1 PI were observed. Hemodialysis with the presence of heparin except of mild shortness of ELT did not influenced the activities of the inhibitors in the plasma of the patients. The decrease of PAI-1 and alfa-2 AP activity with increased FDP concentration in the dialyzed patients can suggests the occurrence of secondary fibrinolysis activation with consumption of these inhibitors.
与对照组相比,在40例慢性肾功能不全的透析患者血浆中观察到抗凝血酶III(AT III)活性轻度降低、纤溶酶原激活物抑制剂-1(PAI-1)和α2抗纤溶酶(α2 AP)活性较低,而α2巨球蛋白(α2 M)和α1抗胰蛋白酶(α1 PI)活性正常。除了部分凝血活酶时间(ELT)轻度缩短外,在肝素存在下进行血液透析对患者血浆中抑制剂的活性没有影响。透析患者中PAI-1和α2 AP活性降低且纤维蛋白降解产物(FDP)浓度升高,这可能提示这些抑制剂消耗导致继发性纤溶激活的发生。